Neurally Adjusted Ventilatory Assist (NAVA) in NonInvasive Ventilation (NIV)
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Aug 30, 2011
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
After written information and consent, patients are randomised in two groups: NAVA first or PSV first.
They receive a NAVA catheter, which has exactly the same appearance as a standard naso-gastric catheter.
A standardised set of 1 hour of non-invasive ventilation is started. Depending on the randomisation group, patients start with a 30 minutes set of NIV with NAVA settings or with a 30 minutes set of NIV with PSV settings. A 30-minute watch-out period is then delivered with no mechanical ventilation.
Then a second 30-minute set of NIV in the other settings (NAVA or PSV depending on the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patient older then 18 years
- • Patient requiring first non invasive ventilation set because of acute respiratory failure
- Exclusion Criteria:
- • Patients protected by the law
- • Pregnant women
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Jean-Michel CONSTANTIN
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials